Clinical Trial Update: Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype [NA]

View source ↗

Summary

Clinical trial update: pembrolizumab is being studied in patients with hypermutator phenotype recurrent malignant glioma; the trial is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• Malignant Glioma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Glioma, Recurrent Malignant Glioma | NA | Status: ACTIVE_NOT_RECRUITING